About 154 million non-elderly Americans rely on employer-sponsored coverage, and the 26th annual survey of more than 2,100 ...

Divi’s Laboratories share price rose 12.02% this week, driven by Citi Research’s ’buy’ rating and a target price of ₹6,400.

Senator Elizabeth Warren told the Federal Trade Commission that the acquisition of contract manufacturer Catalent could ...

Inventive deal structures are on the rise within China’s life sciences industry, with the “NewCo” model having garnered significant interest ...

Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

Health-care costs are going up and and yet, workers may still not get the coverage they want — particularly when it comes to drugs like Ozempic.

Friendships forged during a person's turbulent teenage years lay the essential foundation for their happiness later in life, ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

After investors thought that big healthcare name Eli Lilly & Co. LLY entering the weight loss and GLP-1 market would have been trouble for Hims & Hers, worrying sentiment brought the stock down by as ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

Kelly Osbourne once made her feelings on Ozempic very clear following her mum Sharon’s admission about the medication ...